Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-01 Purchase |
2024-07-03 9:30 pm |
ALUMIS INC. | ALMS | Tananbaum James B. Director 10% Owner |
2,500,000 | $16 | $40,000,000 | 5,379,140 (Indirect) |
View |
| 2024-04-03 Sale |
2024-04-05 4:55 pm |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
13,718,311 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-08-31 Sale |
2023-08-31 5:22 pm |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner |
16,813,146 | $0 | $0 | 2,000 (Indirect Direct) |
View |
| 2023-07-17 Purchase |
2023-07-19 2:54 pm |
Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner |
700,000 | $2.97 | $2,079,000 | 1,385,825 (Indirect) |
View |
| 2023-05-08 Purchase |
2023-05-10 5:49 pm |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
1,780,000 | $2.8 | $4,984,000 | 10,192,354 (Indirect) |
View |
| 2023-04-05 Purchase |
2023-04-06 9:08 pm |
PARDES BIOSCIENCES INC. | PRDS | Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Tananbaum James B. 10% Owner |
773,952 | $1.5 | $1,160,928 | 8,773,134 (Indirect) |
View |
| 2023-04-05 Purchase |
2023-04-06 9:08 pm |
PARDES BIOSCIENCES INC. | PRDS | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner |
773,952 | $1.5 | $1,160,928 | 13,583,762 (Indirect) |
View |
| 2022-12-29 Purchase |
2023-01-03 4:24 pm |
Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner |
500,000 | $5 | $2,500,000 | 1,209,275 (Indirect) |
View |
| 2022-12-01 Purchase |
2022-12-05 4:24 pm |
PARDES BIOSCIENCES INC. | PRDS | Foresite Capital Management V LLC Tananbaum James B. Foresite Capital Fund V L.P. 10% Owner |
637,420 | $0.85 | $541,807 | 12,809,810 (Indirect) |
View |
| 2021-12-22 Purchase |
2021-12-23 4:52 pm |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
325,000 | $10 | $3,250,000 | 325,000 (Indirect) |
View |
| 2021-02-19 Purchase |
2021-02-23 5:34 pm |
FS Development Corp. II | FSII | FS Development Holdings II LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner |
602,500 | $10 | $6,025,000 | 602,500 (Direct) |
View |
| 2020-12-03 Purchase |
2020-12-04 9:39 pm |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
1,000,000 | $20 | $20,000,000 | 125,000 (Indirect) |
View |
| 2020-08-14 Purchase |
2020-10-19 8:49 pm |
FS Development Corp. | FSDC | FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner |
441,500 | $10 | $4,415,000 | 441,500 (Direct) |
View |
| 2020-05-13 Sale |
2020-05-14 6:01 pm |
10x Genomics Inc. | TXG | Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner |
1,450,000 | $80.13 | $116,188,500 | 5,830,911 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-01 Conversion |
2024-07-03 9:30 pm |
N/A N/A |
ALUMIS INC. | ALMS | Tananbaum James B. Director 10% Owner |
11,476,484 | $0 | 5,379,140 (Indirect) |
View |
Ownership |
2024-06-27 9:31 pm |
N/A N/A |
ALUMIS INC. | ALMS | Tananbaum James B. Director 10% Owner |
0 | $0 | 12,652,954 (Indirect) |
View |
| 2023-08-31 Other |
2023-08-31 5:22 pm |
N/A N/A |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner |
1,000 | $0 | 2,000 (Indirect) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:14 pm |
N/A 2033-05-31 |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Director 10% Owner |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-02-17 Other |
2023-02-22 2:50 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
1,100,000 | $0 | 13,038,311 (Indirect) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director |
20,250 | $0 | 20,250 (Direct) |
View |
Ownership |
2022-06-13 5:15 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner |
0 | $0 | 4,294,621 (Indirect) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:33 pm |
N/A 2032-06-07 |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Director 10% Owner |
37,500 | $0 | 37,500 (Direct) |
View |
| 2021-12-23 Option Award(A) |
2022-06-10 4:17 pm |
N/A 2031-12-22 |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-12-23 Conversion(A) |
2021-12-30 4:30 pm |
N/A N/A |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
4,941,250 | $0 | 4,941,250 (Indirect) |
View |
| 2021-12-23 Conversion |
2021-12-28 4:30 pm |
N/A N/A |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
4,873,750 | $0 | 8,761,572 (Indirect) |
View |
| 2021-12-23 Option Award |
2021-12-28 4:30 pm |
N/A 2031-12-22 |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
7,834,072 | $0 | 8,761,572 (Direct) |
View |
| 2021-12-23 Option Award |
2021-12-28 4:30 pm |
N/A N/A |
PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner |
1,000,000 | $10 | 8,761,572 (Indirect) |
View |
| 2021-11-01 Other |
2021-11-03 4:17 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner |
1,963,180 | $0 | 6,628,733 (Indirect) |
View |
| 2021-10-04 Option Award |
2021-10-06 4:15 pm |
N/A 2021-10-03 |
Gemini Therapeutics Inc. | GMTX | Tananbaum James B. Director 10% Owner |
17,245 | $0 | 4,857,495 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:55 pm |
N/A N/A |
Quantum-Si Inc | QSI | Tananbaum James B. Director |
348,125 | $0.001 | 1,618,637 (Indirect) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:55 pm |
N/A N/A |
Quantum-Si Inc | QSI | Tananbaum James B. Director |
5,228,067 | $0 | 1,618,637 (Indirect) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:55 pm |
N/A N/A |
Quantum-Si Inc | QSI | Tananbaum James B. Director |
1,250,000 | $10 | 1,618,637 (Indirect) |
View |
Ownership |
2021-02-16 9:41 pm |
N/A N/A |
FS Development Corp. II | FSII | Tananbaum James B. President and CEO 10% Owner |
0 | $0 | 5,031,250 (Indirect) |
View |
Ownership |
2021-02-10 6:00 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner |
0 | $0 | 6,612,181 (Indirect) |
View |
| 2021-02-05 Conversion |
2021-02-09 4:00 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | Tananbaum James B. Director |
2,928,750 | $0 | 3,370,250 (Indirect) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:00 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | Tananbaum James B. Director |
1,500,000 | $10 | 3,370,250 (Indirect) |
View |
| 2020-12-07 Conversion |
2020-12-09 4:12 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
19,675,448 | $0 | 291,667 (Indirect) |
View |
| 2020-12-02 Option Award |
2020-12-04 6:32 pm |
N/A 2030-12-02 |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
40,501 | $0 | 40,501 (Direct) |
View |
Ownership |
2020-12-02 9:06 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner |
0 | $0 | 9,838,311 (Indirect) |
View |
Ownership(A) |
2020-08-19 9:14 pm |
N/A N/A |
FS Development Corp. | FSDC | Tananbaum James B. President & CEO 10% Owner |
0 | $0 | 3,018,750 (Indirect) |
View |
| 2020-05-12 Conversion |
2020-05-14 6:01 pm |
N/A N/A |
10x Genomics Inc. | TXG | Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner |
1,930,198 | $0 | 5,830,911 (Indirect) |
View |
| 2020-05-06 Conversion |
2020-05-08 08:39 am |
N/A N/A |
10x Genomics Inc. | TXG | Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner |
2,000,000 | $0 | 8,411,109 (Indirect) |
View |